Title
Project: Every Child A Registry, Eligibility Screening, Biology and Outcome Study

Description
You already participated in at least one of the first two parts of the study: The Childhood Cancer Registry and the Eligibility Screening. Now we want your permission for you to continue to be on the other parts of this study. These include tracking outcome where we collect basic information about the treatment you received and how your cancer responded, biobanking for future research which involves saving tissue to be used by researchers later and contact for permission to contact you if there is a future research study about childhood cancer that you might be interested in.

Objective


Your parent(s) or legal guardian(s) agreed to let the Children's Oncology Group (COG) collect information about you and your cancer and now that you are an adult we are asking you to continue being part of this research study


We are doing this study to find better ways to diagnose, treat and prevent cancers in children, adolescents and young adults. To do this, we need to learn more about cancers that happen to children, adolescents and young adults. As most cancers that children get are rare, we can best learn by combining information from as many children with cancer as possible. We would like to continue to collect some information about your cancer and treatment. We would also like to collect extra tumor from procedures done by doctors to help make a diagnosis. In some cases we would also like to collect a small amount of blood, bone marrow, or other tissue from you.

Treatment This study involves collecting information about you and your cancer, and in certain cases, allows research laboratories to study your cancer now and in the future.

Key Eligibility

Patients must be 25 yrs or younger

Patients with a known or suspected carcinoma in situ or malignant histology that occurs in the pediatric, adolescent or young adult populations

Enrollment can occur at any time after disease presentation including at time of disease progression or recurrence

Applicable Disease Sites
Anal; Bladder; Brain/Central Nervous System; Breast; Cervix; Colon and Rectum; Endocrine cancers; Esophagus; Gastrointestinal cancers, other; Genitourinary cancers, other; Head and Neck; Hematologic cancers, other; Kidney; Leukemia; Liver; Lung; Lymphoma; Melanoma/Skin cancer; Ovary; Pancreas; Prostate; Sarcoma; Stomach; Thyroid; Uterus

Participating Institutions
Gundersen Health System; UW Health University Hospital